Vascular dementias;Die vaskulären demenzen

Fortschritte der Neurologie Psychiatrie

Volumn 70, Issue 3, 2002, Pages 145-154

  Diehl, Janine ^a   Kurz, A ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; DONEPEZIL;

AGE; ALZHEIMER DISEASE; AMNESIA; ARTICLE; AUTOPSY; BINSWANGER ENCEPHALOPATHY; BLOOD VESSEL DIAMETER; BRAIN CORTEX; BRAIN INFARCTION; BRAIN PERFUSION; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FRONTAL LOBE; HISTOPATHOLOGY; HUMAN; INTELLECTUAL IMPAIRMENT; MULTIINFARCT DEMENTIA; PATHOGENESIS; PERSONALITY DISORDER; RISK FACTOR; STROKE; SYMPTOMATOLOGY; WHITE MATTER;

BRAIN; DEMENTIA, VASCULAR; HUMANS;

EID: 17644440141     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-20502     Document Type: Article

References (51)

1. Senile dementia of the Binswanger type
2. Frequency and distribution of vascular dementia
3. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales
4. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
5. Vascular dementia: Diagnostic criteria for research studies
6. Binswanger's disease: A review
7. Binswanger's disease
8. Vascular dementia: The role of cerebral infarcts
9. Vaskulär assoziierte demenz
10. Subtypes of vascular dementia
11. How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia
12. Cerebral blood flow in dementia
13. When do strokes cause dementia? Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function
14. Des foyers lacunaires de desintegration et de differents autres etats cavitaires du cerveau
15. Pathogenesis of Binswanger chronic progressive subcortical encephalopathy
16. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people. The Cardiovascular Health study
17. Loss of interhemispheric connectivity in patients with lacunar infarction reflected by diffusion-weighted MR imaging and single-photon emission CT
18. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease
19. Die abgrenzung der allgemeinen progressiven paralyse
20. Binswanger's encephalopathy: A review
21. Which vascular lesions are of importance in vascular dementia?
22. Subcortical vascular dementia as a specific target for clinical trials
23. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
24. Comparison of different clinical criteria (DSM-III, ADDTC, ICD-1O, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia
25. Clinical criteria for the diagnosis of vascular dementia. A multicenter study of comparability and interrater reliability
26. Comparison of seven sets of criteria used for the diagnosis of vascular dementia
27. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia
28. Research criteria for subcortical vascular dementia in clinical trials
29. Vascular cognitive impairment: A new approach to vascular dementia
30. Die bedeutung nuklearmedizinischer verfahren in der demenzdiagnostik
31. Alzheimer's disease: Prevalence and clinical significance of white matter lesions on magnetic resonance imaging
32. Normal pressure hydrocephalus: Predictive value of the cerebrospinal fluid tap-test
33. Vascular dementia: A time to "seize the moment"
34. A population-based model of risk factors for ischemic stroke: Rochester, Minnesota
35. Prevention of stroke in patients with nonvalvular atrial fibrillation
36. The protective effect of moderate alcohol consumption on ischemic stroke
37. Exercise and risk of stroke in male physicians
38. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
39. Vitamins and progression of atherosclerosis in hyperhomocysteinaemia
40. Features, symptoms and neurophysiological findings in stroke associated with hyperhomcysteinaemia
41. European stroke prevention study 2, Dipyrimadole and acetylsalicylic acid in the secondary prevention of stroke
42. A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia
43. Clinical trials of Propentofylline in vascular dementia
44. Memantine in severe dementia: Results of the 9M-Best study (Benefit and Efficacy in Severely Demented Patients During Treatment With Memantine)
45. Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats
46. Galantamine improves cognitive and global abilities in Alzheimer's disease with cerebrovascular components and probable vascular dementia: Preliminary results
47. Results of clinical studies with Donezepil in VAD
48. Die seelenstörungen auf arteriosklerotischer grundlage
49. Brain infarction and the clinical expression of Alzheimer disease. The Nun study